Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.

NAActive, not recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

July 15, 2026

Study Completion Date

May 15, 2027

Conditions
Non-melanoma Skin Cancer
Interventions
DEVICE

Rhenium-SCT

Rhenium-SCT irradiation device

Trial Locations (7)

1160

Klinik Ottakring, Ottakring

2065

Genesis Care Health Hub at RNS, Sydney

4224

John Flynn Hospital, Tugun

6009

Hollywood Private, Perth

18057

Rostock University Hospital, Rostock

0001

Steve Beko Hospital, Pretoria

Unknown

Kings College Hospital London, London

Sponsors
All Listed Sponsors
lead

OncoBeta Therapeutics

INDUSTRY